 |
Ruixue Wang, MD
Principal Research Support Specialist E-mail: Ruixue.Wang@stonybrookmedicine.edu Phone: 631-444-9583 |
Ruixue Wang received her MD from Chongqing Medical University in China. She has over 20 years of experience in animal studies, cell and molecular biology. After joining Dr. Mackenzie’s laboratory Ruixue has been involved in the evaluation of novel agents against cancer using multiple preclinical models.
Selected Publications
- Bartels LE, Mattheolabakis G, Vaeth BM, LaComb JL, Wang R, Komninou D, Rigas B and Mackenzie GG. The novel agent phospho-glycerol-ibuprofen-amide (MDC-330) inhibits glioblastoma growth in mice: An effect mediated by cyclin D1. Carcinogenesis. Apr;37(4):420-9 (2016).
- Mattheolabakis G, Papayannis I, Yang J, Vaeth BM, Wang R, Bandovic J, Ouyang N, Rigas B and Mackenzie GG. Phospho-aspirin (MDC-22) prevents pancreatic carcinogenesis in mice. Cancer Prevention Research (2016), In Press. canprevres.0344.2015.
- Wang R, Clark RA, Mosher DF, Ren XD. (2005) Fibronectin's central cell-binding domain supports focal adhesion formation and Rho signal transduction. Journal of Biological Chemistry 280(31):28803-10. PMID: 15964831
- Ren XD, Wang R, Li Q, Kahek LA, Kaibuchi K, Clark RA. (2004) Disruption of Rho signal transduction upon cell detachment. Journal of Cell Science 117(24): 3511-8. PMID: 15226371
- Liu G, Zhang F, Wang R, London L, London SD. (2014). Protective MCMV immunity by vaccination of the salivary gland via Wharton's duct: replication-deficient recombinant adenovirus expressing individual MCMV genes elicits protection similar to that of MCMV. FASEB Journal 828(4): 1698-710. PMID: 24391133
